about
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.
Read More
1.79
0.01
(0.56%)
10,406
XNAS Volume
XNAS 07 Oct, 2025 4:00 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
BeyondSpring Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..